Sign Up Today and Learn More About Endovascular Engineering Stock
Invest in or calculate the value of your shares in Endovascular Engineering or other pre-IPO companies through EquityZen's platform.
Endovascular Engineering Stock
Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions.
About Endovascular Engineering Stock
Founded
2019
Headquarters
Menlo Park, CA, US
Industries
Blockchain and Crypto, Internet Services, Health Care
Endovascular Engineering Press Mentions
Stay in the know about the latest news on Endovascular Engineering
E2 (Endovascular Engineering, Inc) Presents ENGULF Pivotal Study as a Late-Breaking Clinical Trial at the VIVA Conference
prnewswire • Nov 03, 2025
E2 (Endovascular Engineering, Inc.) Appoints Justin Farry as Chief Financial Officer to Support Next Phase of Growth
prnewswire • Sep 02, 2025
E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism
prnewswire • Jun 23, 2025
E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism
morningstar • Jun 23, 2025
E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism
biospace • Jun 23, 2025
Endovascular Engineering Management
Leadership team at Endovascular Engineering
Founder and President
Luis Savastano
CEO
Dan Rose
Join now and verify your accreditation status to gain access to:
- Endovascular Engineering Current Valuation
- Endovascular Engineering Stock Price
- Endovascular Engineering Management
- Available deals in Endovascular Engineering and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Endovascular Engineering Cap Table and Funding History by Share Class and Liquidity Preferences
- Endovascular Engineering Revenue and Financials
- Endovascular Engineering Highlights
- Endovascular Engineering Business Model
- Endovascular Engineering Risk Factors
- Endovascular Engineering Research Report from SACRA Research
Trading Endovascular Engineering Stock
How to invest in Endovascular Engineering stock?
Accredited investors can buy pre-IPO stock in companies like Endovascular Engineering through EquityZen funds. These investments are made available by existing Endovascular Engineering shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Endovascular Engineering stock?
Shareholders can sell their Endovascular Engineering stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 50K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."